Degarelix versus leuprolide in prostate cancer patients: new prostate-specific antigen data from a phase III trial (CS21)

Tombal, Bertrand;Miller, K.;Boccon-Gibod, L.;Schroder, F.;Persson, B. E.;et.al.
(2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Location: Berlin (Germany) (20.September.2009)

Files

No attached file found for this publication.

Details

Authors
  • Tombal, Bertrandorcid-logoUCLouvain
    Author
  • Miller, K.
    Author
  • Boccon-Gibod, L.
    Author
  • Schroder, F.
    Author
  • Persson, B. E.
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Tombal, B., Miller, K., Boccon-Gibod, L., Schroder, F., Olesen, T. K., & Persson, B. E. (2009). Degarelix versus leuprolide in prostate cancer patients: new prostate-specific antigen data from a phase III trial (CS21). EJC - Supplements, 7(2), 411. https://hdl.handle.net/2078.5/146936 (Original work published 2009)